Celator Pharmaceuticals Report issue

For profit Phase 2 Phase 3
Founded: Princeton NJ United States (1999)
Status: Acquired by Jazz Pharmaceuticals (2016)

Organization Overview

First Clinical Trial
2006
NCT00361842
First Marketed Drug
2017
daunorubicin (cerubidine)
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CELATOR PHARMS